Park Avenue Diabetes Care New York City, NY - 10128

Park Avenue Diabetes Care is categorized under Internal Medicine Doctors in New York City, NY and active since 1988.

Park Avenue Diabetes Care was established in 1988, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Cookie Quinones, Office Manager at the company’s single location by writing to 1150 Park Avenue, New York City, New York NY 10128 or by phoning (212) 427-9191. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Park Avenue Diabetes Care
Contact Person: Cookie Quinones, Office Manager
Address: 1150 Park Avenue, New York City, New York 10128
Phone Number: (212) 427-9191
Annual Revenue (USD): $500.000 to $999.999
Founded: 1988
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Internal Medicine Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Park Avenue Diabetes Care was started in 1988 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Cookie Quinones, Office Manager for inquiries that concern Park Avenue Diabetes Care by calling the company number (212) 427-9191, as your correspondence is most welcome. Additionally, the physical location of the single location of Park Avenue Diabetes Care can be found at the coordinates 40.783824,-73.954649 as well as the street address 1150 Park Avenue in New York City, New York 10128.

For its online presence, you may visit Park Avenue Diabetes Care’s website at and engage with its social media outlets through on Twitter and on Facebook.